Lorigerlimab Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: MGD019

Pipeline

Phase 2: 2

Top Sponsors

MacroGenics1
M.D. Anderson Cancer Center1

Indications

Cancer2
Clear Cell Adenocarcinoma of Peritoneum1
Clear Cell Adenocarcinoma of Fallopian Tube1
Clear Cell Adenocarcinoma of Uterus1
Clear Cell Adenocarcinoma of Cervix1

Los Angeles, California1 trial

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

UCLA

Phase 2

Houston, Texas1 trial

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.